VCELVericel Corp


$ 45.87 $ 1.60 (3.61 %)    

Friday, 13-Sep-2024 15:59:55 EDT
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 45.01
$ 45.84 x 179
-- x --
$ 44.92 - $ 46.64
$ 30.18 - $ 54.10
329,586
na
2.25B
$ 1.63
$ 2,850.46
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-vericel-raises-price-target-to-60

TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $60.

 vericel-gains-fda-approval-for-arthroscopic-delivery-of-maci-in-knee-cartilage-treatments

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today a...

 vericel-corp-files-for-mixed-shelf-offering-size-not-disclosed

- SEC Filing

 vericel-gets-fda-approval-of-nexobrid-for-the-treatment-of-pediatric-patients-with-severe-thermal-burns

Approval Expands NexoBrid Target Customer Base to Include Approximately 20 Pediatric Burn CentersCAMBRIDGE, Mass., Aug. 15, 202...

 expert-ratings-for-vericel
Expert Ratings For Vericel
08/09/2024 14:00:56

 canaccord-genuity-initiates-coverage-on-vericel-with-buy-rating-announces-price-target-of-57

Canaccord Genuity analyst Caitlin Cronin initiates coverage on Vericel (NASDAQ:VCEL) with a Buy rating and announces Price T...

 stephens--co-maintains-overweight-on-vericel-raises-price-target-to-58

Stephens & Co. analyst George Sellers maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-60

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-affirms-fy24-sales-guidance-of-238m-242m-vs-24027m-estimate

2024 Financial Guidance   Reaffirmed total net revenue guidance of $238 to $242 million, or 20% to 23% growth Profitabilit...

 vericel-q2-2024-gaap-eps-010-misses-009-estimate-sales-52662m-beat-52586m-estimate

Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by ...

 truist-securities-maintains-buy-on-vericel-raises-price-target-to-57

Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $56 t...

 btig-maintains-buy-on-vericel-lowers-price-target-to-55

BTIG analyst Ryan Zimmerman maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $56 to $55.

 td-cowen-initiates-coverage-on-vericel-with-buy-rating-announces-price-target-of-55

TD Cowen analyst Joshua Jennings initiates coverage on Vericel (NASDAQ:VCEL) with a Buy rating and announces Price Target of...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-55

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-raises-fy24-revenue-guidance-from-237m-241m-to-238m-242m-vs-23924m-est

2024 Financial GuidanceTotal net revenue for 2024 now expected to be in the range of $238 to $242 million, compared to the prev...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION